Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Viridian Therapeutics, Inc.\DE (VRDN) Other Operating Expenses (2020 - 2025)

Historic Other Operating Expenses for Viridian Therapeutics, Inc.\DE (VRDN) over the last 5 years, with Q3 2025 value amounting to $453000.0.

  • Viridian Therapeutics, Inc.\DE's Other Operating Expenses rose 33230.77% to $453000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $453000.0, marking a year-over-year increase of 33230.77%. This contributed to the annual value of $69.9 million for FY2020, which is N/A changed from last year.
  • Latest data reveals that Viridian Therapeutics, Inc.\DE reported Other Operating Expenses of $453000.0 as of Q3 2025, which was up 33230.77% from -$195000.0 recorded in Q3 2024.
  • Viridian Therapeutics, Inc.\DE's 5-year Other Operating Expenses high stood at $453000.0 for Q3 2025, and its period low was -$195000.0 during Q3 2024.